Non-invasive Neurostimulation for the Relief of Migraine
Non-invasive Neurostimulation of the Vagus Nerve With the gammaCore Device for the Relief of Pain and Allodynia Associated With Migraine
Sponsor: ElectroCore INC
Terminated
Company decision
Other terminated trials from ElectroCore INC
- Crohn Disease · Phase NA · Aug 2022
- Primary Raynaud Phenomenon · Phase NA · Feb 2020
- Seizure · Phase NA · Oct 2014
- Chronic Obstructive Pulmonary Disease · Apr 2013
- Asthma · Phase NA · Jul 2012
More terminations from ElectroCore INC
Other Migraine trials with similar outcome
This NA trial investigates Migraine and is currently terminated or withdrawn. ElectroCore INC leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Oct 2018 — Jan 2021 [monthly]
Terminated NA
-
Aug 2018 — Oct 2018 [monthly]
Terminated NA
-
Jun 2018 — Aug 2018 [monthly]
Terminated NA
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ElectroCore INC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.